Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

China Health Group

BST:TK1
Snowflake Description

Excellent balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TK1
BST
HK$335M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

China Health Group Limited, an investment holding company, engages in the hospital management service and medical equipment and consumables trading businesses in the People's Republic of China. The last earnings update was 103 days ago. More info.


Add to Portfolio Compare Print
  • China Health Group has significant price volatility in the past 3 months.
TK1 Share Price and Events
7 Day Returns
50%
BST:TK1
8.4%
DE Healthcare
9.9%
DE Market
1 Year Returns
50%
BST:TK1
-25.6%
DE Healthcare
-17.5%
DE Market
TK1 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
China Health Group (TK1) 50% -62.5% -88.2% 50% -81.3% -
DE Healthcare 8.4% -16.2% -21.1% -25.6% -43.3% -32%
DE Market 9.9% -16.6% -24.8% -17.5% -24.5% -28.1%
1 Year Return vs Industry and Market
  • TK1 outperformed the Healthcare industry which returned -25.6% over the past year.
  • TK1 outperformed the Market in Germany which returned -17.5% over the past year.
Price Volatility
TK1
Industry
5yr Volatility vs Market

Value

 Is China Health Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for China Health Group. This is due to cash flow or dividend data being unavailable. The share price is €0.003.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for China Health Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are China Health Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:TK1 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in HKD HK$-0.01
SEHK:673 Share Price ** SEHK (2020-03-31) in HKD HK$0.08
Germany Healthcare Industry PE Ratio Median Figure of 9 Publicly-Listed Healthcare Companies 27.51x
Germany Market PE Ratio Median Figure of 399 Publicly-Listed Companies 16.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of China Health Group.

BST:TK1 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:673 Share Price ÷ EPS (both in HKD)

= 0.08 ÷ -0.01

-15.4x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Health Group is loss making, we can't compare its value to the DE Healthcare industry average.
  • China Health Group is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does China Health Group's expected growth come at a high price?
Raw Data
BST:TK1 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -15.4x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.22x
Germany Market PEG Ratio Median Figure of 255 Publicly-Listed Companies 1.18x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for China Health Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on China Health Group's assets?
Raw Data
BST:TK1 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in HKD HK$0.03
SEHK:673 Share Price * SEHK (2020-03-31) in HKD HK$0.08
Germany Healthcare Industry PB Ratio Median Figure of 14 Publicly-Listed Healthcare Companies 1.13x
Germany Market PB Ratio Median Figure of 571 Publicly-Listed Companies 1.43x
BST:TK1 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:673 Share Price ÷ Book Value per Share (both in HKD)

= 0.08 ÷ 0.03

2.73x

* Primary Listing of China Health Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • China Health Group is overvalued based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess China Health Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. China Health Group has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is China Health Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as China Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.4%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is China Health Group expected to grow at an attractive rate?
  • Unable to compare China Health Group's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare China Health Group's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare China Health Group's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
BST:TK1 Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 9.4%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.4%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:TK1 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:TK1 Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2019-09-30 47 -14 -22
2019-06-30 40 -16 -22
2019-03-31 32 -17 -23
2018-12-31 25 -21 -24
2018-09-30 17 -25 -25
2018-06-30 21 -31 -32
2018-03-31 24 -38 -39
2017-12-31 26 -53 -41
2017-09-30 27 -67 -43
2017-06-30 21 -87 -56
2017-03-31 15 -106 -69
2016-12-31 8 -90 -81

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if China Health Group is high growth as no earnings estimate data is available.
  • Unable to determine if China Health Group is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:TK1 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from China Health Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:TK1 Past Financials Data
Date (Data in HKD Millions) EPS *
2019-09-30 -0.01
2019-06-30 -0.01
2019-03-31 -0.01
2018-12-31 -0.01
2018-09-30 -0.01
2018-06-30 -0.01
2018-03-31 -0.01
2017-12-31 -0.01
2017-09-30 -0.01
2017-06-30 -0.02
2017-03-31 -0.02
2016-12-31 -0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if China Health Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine China Health Group's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. China Health Group's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. China Health Group's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess China Health Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
China Health Group has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has China Health Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare China Health Group's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • China Health Group does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare China Health Group's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare China Health Group's 1-year growth to the DE Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
China Health Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from China Health Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:TK1 Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 47.01 -21.50 32.25
2019-06-30 39.60 -22.29 34.99
2019-03-31 32.18 -23.08 37.73
2018-12-31 24.71 -24.07 39.17
2018-09-30 17.24 -25.07 40.61
2018-06-30 20.75 -32.16 44.02
2018-03-31 24.25 -39.25 47.43
2017-12-31 25.79 -41.30 55.55
2017-09-30 27.33 -43.35 63.68
2017-06-30 21.16 -56.32 73.47
2017-03-31 14.99 -69.28 83.26
2016-12-31 8.13 -81.48 81.02
2016-09-30 1.27 -93.69 78.78
2016-06-30 12.49 -83.45 69.49
2016-03-31 23.72 -73.21 60.20
2015-12-31 31.89 -55.44 52.19
2015-09-30 40.06 -37.66 44.19
2015-06-30 38.94 -46.79 37.97
2015-03-31 37.82 -55.93 31.75
2014-12-31 36.74 -76.95 37.19
2014-09-30 35.66 -97.97 42.64
2014-06-30 36.69 -82.77 44.53
2014-03-31 37.72 -67.57 46.43
2013-12-31 35.82 58.12 50.13
2013-09-30 33.92 183.82 53.84
2013-06-30 28.52 162.21 48.85

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if China Health Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if China Health Group has efficiently used its assets last year compared to the DE Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if China Health Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess China Health Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
China Health Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is China Health Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up China Health Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • China Health Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • China Health Group's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of China Health Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • China Health Group has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from China Health Group Company Filings, last reported 6 months ago.

BST:TK1 Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 124.91 0.00 22.03
2019-06-30 124.91 0.00 22.03
2019-03-31 132.05 0.00 30.17
2018-12-31 132.05 0.00 30.17
2018-09-30 140.46 0.00 28.10
2018-06-30 140.46 0.00 28.10
2018-03-31 161.06 0.00 44.20
2017-12-31 161.06 0.00 44.20
2017-09-30 167.29 0.00 53.97
2017-06-30 167.29 0.00 53.97
2017-03-31 110.00 0.00 7.34
2016-12-31 110.00 0.00 7.34
2016-09-30 135.74 0.00 129.02
2016-06-30 135.74 0.00 129.02
2016-03-31 180.38 0.00 205.03
2015-12-31 180.38 0.00 205.03
2015-09-30 43.74 43.80 19.06
2015-06-30 43.74 43.80 19.06
2015-03-31 36.59 103.69 99.08
2014-12-31 36.59 106.19 99.08
2014-09-30 -134.53 219.96 39.61
2014-06-30 -134.53 219.96 39.61
2014-03-31 -100.53 189.38 53.09
2013-12-31 -100.53 189.38 53.09
2013-09-30 -5.84 161.40 27.50
2013-06-30 -5.84 161.40 27.50
  • China Health Group has no debt.
  • China Health Group currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • China Health Group has sufficient cash runway for 1.5 years based on current free cash flow.
  • China Health Group has less than a year of cash runway if free cash flow continues to grow at historical rates of 17.8% each year.
X
Financial health checks
We assess China Health Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. China Health Group has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is China Health Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from China Health Group dividends.
If you bought €2,000 of China Health Group shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate China Health Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate China Health Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:TK1 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 2.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.8%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as China Health Group has not reported any payouts.
  • Unable to verify if China Health Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of China Health Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as China Health Group has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess China Health Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can China Health Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. China Health Group has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of China Health Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ho Chung
COMPENSATION HK$1,668,000
AGE 56
TENURE AS CEO 2.3 years
CEO Bio

Mr. Ho Chung has been an Executive Director at China Health Group Limited since December 28, 2012 and its Chief Executive Officer since December 11, 2017. Mr. Chung has over 20 years of experience in investment, financing, corporate management and other areas and has worked in several investment institutions and companies in Mainland China and Hong Kong as senior manager and director. Mr. Chung graduated from Shanghai Railway University with a Bachelor Degree in Science and Technology and from the Central University of Finance and Economics with a Master Degree in Economics.

CEO Compensation
  • Ho's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Ho's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the China Health Group management team in years:

2.2
Average Tenure
53.5
Average Age
  • The tenure for the China Health Group management team is about average.
Management Team

Fan Zhang

TITLE
Chairman of the Board
COMPENSATION
HK$1M
AGE
54

Ho Chung

TITLE
CEO & Executive Director
COMPENSATION
HK$2M
AGE
56
TENURE
2.3 yrs

Jingming Wang

TITLE
Hospital Chief Executive & Executive Director
COMPENSATION
HK$2M
AGE
62
TENURE
2.3 yrs

Peiyuan Qiu

TITLE
Senior Consultant
COMPENSATION
HK$83K
AGE
53
TENURE
0.6 yrs

Jiuru Ding

TITLE
Chief Financial Officer
AGE
56
TENURE
2.1 yrs

Amy Yu

TITLE
Chief Operating Officer and Vice President
AGE
45

Pei Lu

TITLE
Chief Medical Director and Vice President of Customer Services
AGE
53

Raymond Tsui

TITLE
Company Secretary
AGE
43
Board of Directors Tenure

Average tenure and age of the China Health Group board of directors in years:

3
Average Tenure
53.5
Average Age
  • The average tenure for the China Health Group board of directors is less than 3 years, this suggests a new board.
Board of Directors

Fan Zhang

TITLE
Chairman of the Board
COMPENSATION
HK$1M
AGE
54
TENURE
2.3 yrs

Ho Chung

TITLE
CEO & Executive Director
COMPENSATION
HK$2M
AGE
56
TENURE
7.3 yrs

Jingming Wang

TITLE
Hospital Chief Executive & Executive Director
COMPENSATION
HK$2M
AGE
62
TENURE
5.9 yrs

Xuejun Jiang

TITLE
Independent Non-Executive Director
COMPENSATION
HK$100K
AGE
51
TENURE
3.2 yrs

Yu Weng

TITLE
No-Executive Director
COMPENSATION
HK$562K
AGE
39
TENURE
3.8 yrs

Yong Xing

TITLE
Non-Executive Director
COMPENSATION
HK$300K
AGE
54
TENURE
3.8 yrs

Lianhai Huang

TITLE
Non-Executive Director
COMPENSATION
HK$100K
AGE
38
TENURE
2.8 yrs

Yanhua Du

TITLE
Independent Non-Executive Director
COMPENSATION
HK$100K
AGE
53
TENURE
2.3 yrs

Liangquan Lai

TITLE
Independent Non-Executive Director
AGE
42
TENURE
1.1 yrs

Yongming Wang

TITLE
Non-Executive Director
AGE
57
TENURE
0.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
27. Jun 19 Sell Coral Point Global Limited Company 21. Jun 19 21. Jun 19 -15,000,000 €0.01 €-193,381
X
Management checks
We assess China Health Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. China Health Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

China Health Group Limited, an investment holding company, engages in the hospital management service and medical equipment and consumables trading businesses in the People's Republic of China. It is also involved in business factoring and finance leasing business, as well as property investment business. The company was formerly known as China HealthCare Holdings Limited and changed its name to China Health Group Limited in September 2015. China Health Group Limited is headquartered in Central, Hong Kong.

Details
Name: China Health Group Limited
TK1
Exchange: BST
Founded:
HK$39,198,706
4,139,947,634
Website: http://www.ch-groups.com
Address: China Health Group Limited
China Insurance Group Building,
Unit 801,
Central,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 673 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 18. Jun 2001
BST TK1 Ordinary Shares Boerse-Stuttgart DE EUR 18. Jun 2001
Number of employees
Current staff
Staff numbers
41
China Health Group employees.
Industry
Health Care Distributors
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/01 02:33
End of day share price update: 2020/03/31 00:00
Last earnings filing: 2019/12/20
Last earnings reported: 2019/09/30
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.